Tracked deals
3
3 tracked deals across 2019-2026.
London, England, United Kingdom
At WTW (NASDAQ: WTW), we provide data-driven, insight-led solutions in people, risk and capital—helping organizations sharpen strategy, enhance resilience, motivate their workforce, and maximize performance.
Tracked deals
3
3 tracked deals across 2019-2026.
Recent pace
2
2 tracked deals announced in the last 12 months.
Deal mix
Buyout
3 buyout
Last 2 years
Supporting Data
WTW has announced the acquisition of Redefind, an end-to-end web-based platform that enables individuals and institutions to buy insurance for cryptocurrency and other digital assets. The deal is intended to strengthen WTW’s digital strategy and integrate Redefind into its Affinity practice to expand distribution across WTW’s global client base. Financial terms were not disclosed, and Redefind founders Richard Daws and Connor Edward are set to join WTW upon completion.
WTW completed its acquisition of FlowStone Partners, LLC on April 1, 2026. The deal adds private equity secondaries expertise to WTW’s Investments business to expand private markets solutions for individual wealth and institutional clients (financial terms undisclosed).
Willis Towers Watson has acquired TRANZACT, a U.S. direct-to-consumer sales and marketing platform for Medicare and individual life insurance, from private equity firm Clayton, Dubilier & Rice for approximately $1.2–1.3 billion (including potential earn-out). The acquisition adds TRANZACT's technology-driven lead generation, sales execution and analytics capabilities — and its ~1,300 employees (including ~850 licensed agents) — to Willis Towers Watson's Benefits Delivery and Administration business to accelerate its direct-to-consumer strategy.
Turn tracked acquisition activity into an outreach-ready buyer list.